Suppr超能文献

取代 N-苯基吡嗪-2-甲酰胺:合成与抗分枝杆菌活性评价。

Substituted N-Phenylpyrazine-2-carboxamides: synthesis and antimycobacterial evaluation.

机构信息

Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic.

出版信息

Molecules. 2009 Oct 20;14(10):4180-9. doi: 10.3390/molecules14104180.

Abstract

The condensation of chlorides of substituted pyrazinecarboxylic acids with ringsubstituted anilines yielded twelve substituted pyrazinecarboxylic acid amides. The synthetic approach, analytical, and lipophilicity data of the newly synthesized compounds are presented. Two antituberculosis assays were used. Firstly, the antimycobacterial activity against four different Mycobacterium strains in a series of pyrazine derivatives was investigated. Secondly, the antimycobacterial evaluation was performed at the Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) program. Interesting in vitro antimycobacterial activity was found, N-(3-iodo-4-methylphenyl) pyrazine-2-carboxamide (9) was most active derivative compound against M. tuberculosis (MIC < 2.0 micromol/L), while another iodo derivative 5-tert-butyl-6-chloro-N-(3-iodo-4-methyl-phenyl)pyrazine-2-carboxamide (12) was the most active compound in the TAACF antituberculosis screening program (IC(90) = 0.819 microg/mL).

摘要

取代的吡嗪羧酸的氯化物与取代的苯胺环缩合生成了十二个取代的吡嗪羧酸酰胺。本文介绍了新合成化合物的合成方法、分析和脂溶性数据。采用了两种抗结核检测方法。首先,在一系列吡嗪衍生物中研究了对四种不同分枝杆菌菌株的抗分枝杆菌活性。其次,在结核病抗菌药物获取和协调机构(TAACF)方案中进行了抗分枝杆菌评价。发现了有趣的体外抗分枝杆菌活性,N-(3-碘-4-甲基苯基)吡嗪-2-甲酰胺(9)是对结核分枝杆菌(MIC <2.0 微摩尔/升)最有效的衍生物化合物,而另一种碘代衍生物 5-叔丁基-6-氯-N-(3-碘-4-甲基苯基)吡嗪-2-甲酰胺(12)是 TAACF 抗结核筛选方案中最有效的化合物(IC(90)=0.819 微克/毫升)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aadf/6255326/ee342cdebd2e/molecules-14-04180-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验